(IMVT) |
| 0 (0%) 04-14 16:55 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 31.49 |
| Resistance 1: | 26.96 |
| Pivot price: | 24.80 |
| Support 1: | 24.38 |
| Support 2: | 22.79 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.670 |
| Book Value | 4.850 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -41.3 |
| Return on Equity (ttm) | -69.3 |
Company news
Sat, 11 Apr 2026
Should Batoclimab’s Phase 3 Miss in Thyroid Eye Disease Require Action From Immunovant (IMVT) Investors? - simplywall.st
Fri, 10 Apr 2026
Van Tuyl, Immunovant’s chief legal officer, sells $128k in IMVT stock - Investing.com
Fri, 10 Apr 2026
Immunovant (IMVT) CTO stout sells $251k in shares - Investing.com
Fri, 10 Apr 2026
Immunovant (IMVT) CLO sells 5,165 shares to cover RSU tax bill - Stock Titan
Fri, 10 Apr 2026
[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan
Fri, 10 Apr 2026
Immunovant (NASDAQ: IMVT) CTO sells 10,132 shares for RSU tax obligations - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
